Menu
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

iShares Biotechnology ETF (NQ:IBB)

167.34 -1.66 (-0.98%)
Official Closing Price Updated: 4:15 PM EST, Jan 5, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about iShares Biotechnology ETF

< Previous 1 2
...
5 6 7 8 9 10 11 12 13
...
27 28 Next >
News headline image
Bullish Reversals ↗
Agricultural commodities have fallen a lot lately. Food supply and shortages remain a concern going into the spring and summer growing seasons. 
Via Talk Markets
News headline image
FDA Takes Action To Restrict Unlawful Import Of Animal Tranquilizer 'Tranq' Or ''Zombie Drug' ↗
 
Via Benzinga
News headline image
Century Aluminum Pops Up As Bullish ↗
Given the recent sell-off in aluminum, copper, and steel, industrial metals remain overall outperformers. 
Via Talk Markets
News headline image
Stock Market Forecast: Stocks May Drop Further As Rates Rise ↗
This week will be full of economic insights, but the big data will be the ISM manufacturing and services indexes. However, I think these two reports are unlikely to do much to reverse the current trend... 
Via Talk Markets
News headline image
No Landing - Sugar Coated Words For Stagflation? ↗
SPX failed the 23-month moving average or 2-year business cycle, which if clears, signals a softer landing. Yet, it held the pivotal 3900 ahead of the Fed, signaling a no landing. 
Via Talk Markets
News headline image
Is The Whole Country Buying Teslas And Eating At Wingstop? ↗
XRT is making lower highs each of the last 3 weeks but also has found a basis of support at 68.00. 
Via Talk Markets
News headline image
Tuesday Talk: My Sweet CPI ↗
The street is hoping for sweet January CPI data today and that anticipation pushed stocks higher on Monday. 
Via Talk Markets
News headline image
Large-Cap Biopharmaceuticals: Bearish Sentiment Curbs Buyers ↗
Large cap biopharma stocks are off their highs despite reasonable valuations plus dividends. 
Via Talk Markets
News headline image
ARK Invest: The 7 Words That Explain Why Wall Street Can’t Stand Cathie Wood ↗
Why does Wall Street hate Cathie Wood and her ARKK ETF? Seven words show how her focus on innovation divides investors. 
Via InvestorPlace
News headline image
2-Year Business Cycles Matter In Commodities ↗
Gold is above the 23-month MA and the 2-year business cycle. 
Via Talk Markets
News headline image
2-Year Business Cycles Matter In This Market ↗
In October, IWM held the 80-month and got us believing that a recession would be averted. Now, the market literally hangs in the balance between a longer-term and a shorter-term business cycle. 
Via Talk Markets
News headline image
When Small Cap Biotechs Lose Momentum: Are You An Investor Or A Trader? ↗
A few small cap biotechs lost momentum last week so now might be the time to take profits. But many of these stocks are favored because of their core technology and favored by funds; time to buy? 
Via Talk Markets
News headline image
February PDUFA Catalysts Biotech Investors Must Know: Sanofi's Bleeding Disorder Drug, Regeneron's Twin Eylea Label Expansions, 3 Delayed Approvals And More ↗
The year has started well for biopharma companies on the regulatory front, as most decisions handed out during January were positive. The Food and Drug Administration has already cleared four new... 
Via Benzinga
News headline image
Sector Shift Stalls Healthcare Stocks But Biotech Shows Gains In January ↗
Biotech stocks are off to a great start in 2023 with the IBB up 4.5% and the XBI up 7.7%. 
Via Talk Markets
News headline image
What Are The Equities Market’s Warning Signs? ↗
The 52-week New High / New Low ratio for the Nasdaq Composite has actually begun to deteriorate, a clear Risk-Off indication for the short term. 
Via Talk Markets
News headline image
Inflation, What Inflation? ↗
We typically have a song or two in our heads. After all, watching ticks is musical and has a lot of different beats. And typically, those songs turn into parodies. 
Via Talk Markets
News headline image
Global Stocks: Breaking Out? ↗
The S&P 500 is attempting to clear what has been an insurmountable trendline dating back to January 2022. 
Via Talk Markets
News headline image
The 3 Best Biotech Stocks Under $1 to Buy for January ↗
Even the best small biotech stocks can go bust on a single bad study, but the winners can make their early investors rich. 
Via InvestorPlace
News headline image
Longeveron Shares Surge Following FDA Decision on Biogen Alzheimer's Drug ↗
Shares of Longeveron (NASDAQ: LGVN) are trading 5.37% higher amid strength in Alzheimer's-related stocks after the FDA granted accelerated approval to Biogen (NASDAQ: BIIB)'s Leqembi.  
Via Benzinga
News headline image
SAVA, LLY, IBB: Why These Alzheimer's Related Stocks Are Volatile On Friday ↗
Stocks of companies with Alzheimer's candidates, including Cassava Sciences, Inc. (NASDAQ: SAVA) and Eli Lilly And Company (NYSE: LLY), spiked on Friday after the FDA granted accelerated approval to 
Via Benzinga
News headline image
Biogen's 2nd Alzheimer's Antibody, BeiGene's Cancer Drug Label Expansion, Adcom Test For Regeneron And More: January PDUFA Catalysts For Biotech Investors ↗
Biopharma stocks were not immune to the broader market downturn seen for much of 2022. 
Via Benzinga
News headline image
Healthcare Portfolio Is Doing Well But Biotech Stocks Are Mired In Macro ↗
The biotech sector has not done well in 2022 despite some strong runs. Small and mid-cap stocks are more “risk-off’ with interest rates rising and sentiment waning. 
Via Talk Markets
News headline image
Tarsus Added to NASDAQ Biotechnology Index
From Tarsus Pharmaceuticals, Inc
Via GlobeNewswire
News headline image
Small Caps Vs Large Caps: Who Is Leading? ↗
Clearly, large-cap stocks have been leading with the Dow Jones down the last year to date, but even though the selling pressure has been constant, trading volume has been anemic. 
Via Talk Markets
News headline image
Meta Platforms, This Biotech ETF And These China Plays Are CNBC's 'Final Trades' ↗
The iShares Biotechnology ETF (NASDAQ: IBB), which includes several large cap biotechs, has recently narrowed its year-to-date loss to aroun 
Via Benzinga
BriaCell’s Lead Candidate Bria-IMT™ Shows Promising Results For Advanced Breast Cancer Patients
The world of biotech is having what some are calling a golden age. Many companies are presenting new and innovative drugs to the FDA for approval and later the public for consumption. Smart Beta EFTs... 
Via TheNewswire.com
Topics Stocks
News headline image
BriaCell’s Lead Candidate Bria-IMT™ Shows Promising Results For Advanced Breast Cancer Patients
By Faith Ashmore, Benzinga 
Via News Direct
News headline image
Mirati Plays Catch-Up With Amgen, Gilead's 2nd Try With AIDS Drug, Cytokinetics' Adcom Test And More: Key Nov FDA Decisions For Biotech Investors ↗
Food and Drug Administration decisions and advisory committee verdicts slated for November were mostly positive. New molecular entity approvals so far this year trail 2021’s tally by about 35%. 
Via Benzinga
News headline image
BriaCell's Lead Candidate Bria-IMT™ Shows Promising Results For Advanced Breast Cancer Patients ↗
The world of biotech is having what some are calling a golden age. Many companies are presenting new and innovative drugs to the FDA for approval and later the public for consumption. 
Via Benzinga
News headline image
Will The Dow Jones Continue Higher? Will The Nasdaq Follow? ↗
It's been a volatile few weeks in the markets, and it can be hard to tell if we're currently in a risk-on or risk-off environment. 
Via Talk Markets
< Previous 1 2
...
5 6 7 8 9 10 11 12 13
...
27 28 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.